Side Effects of Clonazepam
Clonazepam commonly causes drowsiness (approximately 50% of patients), problems with walking and coordination/ataxia (approximately 30%), dizziness, depression, fatigue, and memory problems. 1
Most Common Side Effects
The FDA-approved labeling and clinical guidelines consistently identify these primary adverse effects 1:
- Drowsiness/Somnolence - occurs in ~50% of seizure patients and 7% discontinue panic disorder treatment due to this
- Ataxia and coordination problems - affects ~30% of patients; particularly concerning for falls
- Dizziness
- Depression - 4% of panic disorder patients discontinue due to this
- Fatigue and weakness
- Memory problems and cognitive impairment - including amnesia and reduced intellectual ability
Serious and Concerning Side Effects
In Older Adults and Neurodegenerative Disease Patients
Clonazepam poses particularly high risks in older adults and should be used with extreme caution. The 2023 American Academy of Sleep Medicine guideline specifically warns that concerning side effects include 2:
- Morning sedation
- Gait imbalance and falls risk
- Cognitive disturbances, specifically delirium and amnesia
- Depression
- Exacerbation of sleep-disordered breathing
The guideline notes that clonazepam is listed on the American Geriatrics Society Beers Criteria as a potentially inappropriate medication in older adults 2. Among patients with neurodegenerative diseases like Parkinson's or dementia, progressive cognitive decline combined with age-related impairments in drug metabolism often leads to gradual intolerance, even at lower starting doses of 0.25 mg 2.
Behavioral and Psychiatric Effects
Behavioral problems occur in approximately 25% of patients 1. Paradoxical reactions can occur, including 1:
- Irritability, aggression, and agitation
- Nervousness, hostility, and anxiety
- Sleep disturbances and nightmares
- Hallucinations
- Confusion and psychosis (more likely in patients with psychiatric history)
Respiratory Depression
When combined with opioids, clonazepam can cause severe drowsiness, respiratory depression, coma, and death 1. This represents a critical drug interaction that must be avoided.
Dependence and Withdrawal
Clonazepam causes physical dependence and tolerance with prolonged use, and abrupt discontinuation can trigger life-threatening seizures (status epilepticus) 1, 3. The FDA labeling explicitly warns that stopping suddenly can cause 1:
- Seizures that will not stop (status epilepticus)
- Hallucinations
- Shaking and tremors
- Stomach and muscle cramps
Research demonstrates that discontinuation symptoms during gradual tapering are typically mild and include anxiety, tremor, nausea, insomnia, excessive sweating, tachycardia, headache, weakness, and muscle aches 4. However, these symptoms only remain mild when the medication is tapered very slowly (0.25 mg per week after reaching 1 mg/day) 4.
Less Common but Notable Side Effects
Additional adverse effects reported in clinical trials include 1:
- Respiratory: Chest congestion, shortness of breath, hypersecretion
- Gastrointestinal: Nausea, changes in appetite
- Genitourinary: Dysuria, urinary retention
- Hematologic: Anemia, leukopenia, thrombocytopenia
- Hepatic: Elevated liver enzymes
- Neurologic: Diplopia, dysarthria, nystagmus, vertigo, headache
- Other: Weight changes, fever
Clinical Context
The side effect profile varies somewhat by indication. In panic disorder trials, 17% of patients discontinued due to adverse events compared to 9% on placebo 1. The most effective doses (1-2 mg daily) offered the best balance of therapeutic benefit and tolerability 5.
The key clinical pitfall is underestimating the cognitive and motor impairment risks, particularly in older adults, and failing to taper slowly enough when discontinuing. Patients must be explicitly warned not to drive or operate machinery until they know how the medication affects them, and to avoid alcohol and other CNS depressants 1.